Skip to content

Effect of Frankincense Versus Palatal Stent on Palatal Donor Site Healing

Effect of Frankincense Versus Palatal Stent on Palatal Donor Site Healing: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07772011
Enrollment
28
Registered
2026-08-19
Start date
2026-04-30
Completion date
2027-03-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palatal Donor Site Wound Healing

Keywords

Frankincense, Boswellia serrata, Palatal wound healing, Palatal donor site, Free gingival graft, Palatal stent

Brief summary

This randomized controlled clinical trial will evaluate the effect of a natural frankincense-based gel on healing of the palatal donor site after soft tissue graft harvesting. A total of 28 adult participants requiring a free gingival graft or connective tissue graft will be randomly assigned in a 1:1 ratio to one of two groups. The intervention group will receive topical frankincense gel applied to the palatal wound together with a palatal stent, while the control group will receive a palatal stent only. Participants will be followed for 30 days. The study will assess patient satisfaction, postoperative pain, wound epithelialization, wound surface area, and wound healing

Detailed description

Participants undergoing palatal soft tissue harvesting for periodontal plastic surgical procedures will be recruited from the outpatient clinic of the Oral Medicine and Periodontology Department, Faculty of Dentistry, Cairo University. Eligible participants will be randomly allocated in a 1:1 ratio into two parallel groups. In the experimental group, a continuous thin layer of natural frankincense-based gel will be applied topically to the denuded palatal donor site following graft harvesting, followed by placement of a palatal stent. In the comparator group, the palatal donor site will be managed using a palatal stent only. The frankincense gel is prepared using Boswellia serrata extract in an aqueous gel formulation. The palatal soft tissue graft will be harvested using a standardized surgical approach, and graft dimensions and residual palatal mucosal thickness will be recorded. Participants will be followed for 30 days. Patient satisfaction will be assessed using a 7-point Likert scale. Postoperative pain will be evaluated using a Visual Analog Scale from 0 to 10. Wound epithelialization will be assessed using 3% hydrogen peroxide, wound surface area will be evaluated from clinical photographs using image analysis, and wound healing will be evaluated using the Landry, Turnbull, and Howley Healing Index.

Interventions

DRUGFrankincense Gel

Topical application of a natural frankincense-based gel containing Boswellia serrata to the denuded palatal donor site after free gingival graft harvesting. The gel is applied as a continuous thin layer and followed by placement of a palatal stent.

A palatal stent will be placed over the palatal donor site after free gingival graft harvesting to provide postoperative protection.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor and statistician will be blinded to group allocation.

Intervention model description

Participants will be randomly assigned in a 1:1 ratio to two parallel groups: frankincense gel with palatal stent or palatal stent only

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years. * Patients scheduled for a free gingival graft or connective tissue graft requiring a palatal donor site. * ASA physical status I-II

Exclusion criteria

* Known allergy or hypersensitivity to frankincense, Boswellia species, or frankincense formulation excipients. * Current smoker or tobacco user. * Uncontrolled systemic disease, such as uncontrolled diabetes mellitus. * Pregnant or lactating females

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction Scores Assessed Using a 3-Item, 7-Point QuestionnaireDay 30Patient satisfaction will be assessed using a 3-item questionnaire evaluating willingness to undergo the same procedure again, willingness to recommend the surgical procedure to others, and overall satisfaction with the results. Each item will be rated on a 7-point scale ranging from 1 to 7, where higher scores indicate greater willingness or satisfaction. The score for each questionnaire item will be reported separately

Secondary

MeasureTime frameDescription
Pain PerceptionDays 3, 7, and 14Postoperative pain will be assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates severe pain.
Wound EpithelializationDays 14, 21, and 30Wound epithelialization will be assessed using 3% hydrogen peroxide. Complete epithelialization will be recorded according to the presence or absence of bubbling over the wound surface.
Wound Surface Areaup to 30 daysWound surface area will be assessed from standardized oral photographs using image analysis software and reported in square millimeters.
Wound HealingDays 3, 7, 14, 21, and 30Wound healing will be assessed using the Landry, Turnbull, and Howley Healing Index, with scores ranging from 1 (very poor healing) to 5 (excellent healing).
Postoperative BleedingDays 3, 7, and 14

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORHAWRA FUAD ALI Mulla ALI, BDS

Cairo University

STUDY_CHAIRDr.Manal Hosny

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026